Comparison of Three Shortened Questionnaires for Assessment of Quality of Life in Advanced Cancer

Chiu, Leonard; Chiu, Nicholas; Chow, Edward; Cella, David; Beaumont, Jennifer L.; Lam, Henry; Popović, Marko; Bedard, Gillian; Poon, Michael; Wong, Erin; Zeng, Liang; Bottomley, Andrew

doi:10.1089/jpm.2014.0012

Cited by 18 publications

(12 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The FACT-G7's weaker relations with psychosocial indices support conclusions from previous literature that the FACT-G7 does not reflect social and emotional aspects of quality of life as much as symptom-related concerns. 35 However, further studies may evaluate the clinical utility of individual items in alerting clinicians quickly to the possible presence of emotional distress ("I worry that my condition will get worse," "I am able to enjoy life") as well as relevant symptoms ("I have pain," "I have a lack of energy") that may benefit from detailed assessment.…”

Section: Discussionmentioning

confidence: 99%

Validation of the 7‐item Functional Assessment of Cancer Therapy‐General (FACT‐G7) as a short measure of quality of life in patients with advanced cancer

Mah

Swami

et al. 2020

Cancer

View full text Add to dashboard Cite

BACKGROUND: Assessing quality of life is essential for individuals with advanced cancer, but lengthy assessments can be burdensome. The authors investigated the psychometric characteristics of the FACT-G7, a 7-item quality-of-life measure derived from the Functional Assessment of Cancer Therapy-General (FACT-G) scale, in advanced cancer. METHODS: Data were obtained from outpatients with advanced cancer who were enrolled in a randomized controlled trial of early palliative care. At baseline, 228 intervention participants and 233 control participants (N = 461) completed the FACT-G and measures of symptom severity, quality of life near the end of life, problematic medical communication, and satisfaction with care. Follow-up measures were administered monthly for 4 months. RESULTS: The FACT-G7 showed good internal consistency (Cronbach α = .72-.80), and its single-factor structure was supported. It correlated strongly with the FACT-G total, physical, and functional indices and with symptom severity (absolute r = 0.73-0.92); more moderately with the FACT-G emotional index and with symptom impact and preparation for the end of life (r = .40-.71); and least with the FACT-G social/ family index and with relationship with health care provider, life completion, problematic medical communication, and care satisfaction measures (absolute r = .26-.44). Eastern Cooperative Oncology Group performance status groups differed on FACT-G7 scores, as expected (all P < .001). Improvements in FACT-G7 scores in the intervention group compared with the control group at 3-month (P = .049) and 4-month (P = .034) follow-up supported responsiveness to change and somewhat greater sensitivity than the FACT-G scores. CONCLUSIONS: The FACT-G7 is a valid, brief measure particularly of the physical and functional facets of quality of life. It may enable rapid quality-of-life assessments in patients with advanced cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

Validation of the 7‐item Functional Assessment of Cancer Therapy‐General (FACT‐G7) as a short measure of quality of life in patients with advanced cancer

Mah

Swami

et al. 2020

Cancer

View full text Add to dashboard Cite

show abstract

“…EORTC QLQ-C15-PAL consists of 15 items and 10 subscales. It is a short version of QLQ-C30, which is in widespread use in cancer research, adapted and validated for palliative care (38).…”

Section: Measuring Methodsmentioning

confidence: 99%

Music Therapy in Palliative Care

Warth¹,

Keßler²,

Hillecke³

et al. 2015

Deutsches Ärzteblatt International

View full text Add to dashboard Cite

show abstract

“…Of all the existing cancer specific HRQOL instruments, the European Organization for Research and Treatment of Cancer Quality of Life Questionnnaire-C30 (QLQ-C30) is among the most commonly known and used in Europe while the Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of Chronic Illness Therapy (FACIT) are more widespread in the United States (10)(11)(12)(13). The QLQ-C30 was first developed in 1987 (as QLQ-C36), and was subsequently developed in 1997 into the version used today (version 3.0).…”

Section: Introductionmentioning

confidence: 99%